Patents by Inventor Myung Eun Jung

Myung Eun Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SULFUR CONTAINING PYRAZOLE-HETEROCYCLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS
    Publication number: 20110178140
    Abstract: A novel sulfur containing heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The prevention also provide a method for preparing same, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
    Type: Application
    Filed: September 25, 2008
    Publication date: July 21, 2011
    Applicant: GREEN CROSS CORPORATION
    Inventors: Jinhwa Lee, Hee Jeong Seo, Min-Ah Kim, Jeongmin Kim, Sung-Han Lee, Myung Eun Jung, Mi-Soon Kim
  • Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
    Patent number: 7875647
    Abstract: A heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing the inventive heteroaryl-pyrasole compounds or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: January 25, 2011
    Assignee: Green Cross Corporation
    Inventors: Jinhwa Lee, Jeong Min Kim, Chong-Hwan Jonathan Chang, Suk Ho Lee, Hee Jeong Seo, Suk Youn Kang, Kwang-Seop Song, Jong Yup Kim, Min-ah Kim, Sung-han Lee, Kwang-Woo Ahn, Myung Eun Jung, Ji-Hyun Park
  • ORALLY BIOAVAILABLE PRODUCTS OF (+)-3-HYDROXYMORPHINAN FOR PARKINSON'S DISEASE PREVENTION OR TREATMENT
    Publication number: 20100113500
    Abstract: The present invention is directed to a novel prodrug of (+)-3-hydroxymorphinan compound of formula (I) or a pharmaceutically acceptable salt thereof, a method for preparing the same, and its use for preventing or treating Parkinson's disease.
    Type: Application
    Filed: March 7, 2008
    Publication date: May 6, 2010
    Applicant: GREEN CROSS CORPORATION
    Inventors: Jinhwa Lee, Jeongmin Kim, Myung Eun Jung, Jong Yup Kim, Kwang-Seop Song, Eun Jung Son, Suk Ho Lee, Ho Kyun Han, Min Ju Kim, MinWoo Lee
  • Azole Derivatives as Cannabinoid CB1 Receptor Antagonists
    Publication number: 20080262066
    Abstract: A novel azole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The prevention also provides a method for preparing same, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
    Type: Application
    Filed: April 18, 2008
    Publication date: October 23, 2008
    Applicant: Green Cross Corporation
    Inventors: Jinhwa LEE, Jeongmin Kim, Kwang-Seop Song, Min Ah Kim, Jong Yup Kim, Suk Ho Lee, Hee Jeong Seo, Sung-Han Lee, Myung Eun Jung, Kwang Woo Ahn, Eun Jung Son
  • HETEROARYL-IMIDAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS
    Publication number: 20080207704
    Abstract: A heteroaryl-imidazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing a heteroaryl-imidazole compound of formula (I), a pharmaceutical composition containing a heteroaryl-imidazole compound of formula (I), and a method for preventing or treating obesity and obesity-related metabolic disorders.
    Type: Application
    Filed: February 27, 2007
    Publication date: August 28, 2008
    Applicant: THE GREEN CROSS CORPORATION
    Inventors: Jinhwa Lee, Jeongmin Kim, Jong Yup Kim, Hee Jeong Seo, Myung Eun Jung, Sung-Han Lee, Kwangwoo Ahn
  • Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor Antagonists
    Publication number: 20080207705
    Abstract: A novel heteroaryl-imidazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing same, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
    Type: Application
    Filed: February 27, 2008
    Publication date: August 28, 2008
    Applicant: Green Cross Corporation
    Inventors: Jinhwa LEE, Jeongmin Kim, Jong Yup Kim, Hee Jeong Seo, Myung Eun Jung, Sung-Han Lee, Kwangwoo Ahn, Suk Ho Lee
  • Heteroaryl-Pyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists
    Publication number: 20080081812
    Abstract: A heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing the inventive heteroaryl-pyrasole compounds or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
    Type: Application
    Filed: September 28, 2007
    Publication date: April 3, 2008
    Applicant: Green Cross Corporation
    Inventors: Jinhwa LEE, Jeong Kim, Chong-Hwan Chang, Suk Lee, Hee Seo, Suk Kang, Kwang-Seop Song, Jong Kim, Min-ah Kim, Sung-han Lee, Kwang-Woo Ahn, Myung Eun Jung, Ji-Hyun Park